Scimplify Secures $40M in Series B to Accelerate Revolution in Specialty Chemical Manufacturing

We are excited to announce that Scimplify, a science-first company for end-to-end development and manufacturing of specialty chemicals, has successfully raised $40,000,000 in our latest funding round. This pivotal investment will empower us to further revolutionize the specialty chemical industry by enhancing our comprehensive offerings, which span from contract research and custom synthesis to the commercial manufacturing of a wide array of products across Pharmaceuticals, Agrochemicals, Industrial Chemicals, Flavors & Fragrances, Food & Nutrition, Beauty & Personal Care, and more. With this new capital, we will accelerate our mission to support businesses globally throughout the entire product life cycle, ensuring they receive highly specialized assistance from ideation to full-scale production. Central to our strategy is our proprietary platform, ATOMS, which is transforming how companies connect with chemical manufacturers. ATOMS simplifies procurement by providing real-time visibility into production processes, reducing lead times, and enforcing 100% regulatory compliance. With over 25+ reaction capabilities housed under one roof, our in-house team of R&D experts and scientists is already setting new industry standards in custom synthesis and route scouting. The additional funding will be deployed to further develop ATOMS, expand our reaction capabilities, and increase our global outreach, ensuring that manufacturers can efficiently access unutilized capacity while businesses make faster, more informed decisions in chemical development and production. This funding not only marks a significant milestone in our growth story but also solidifies our commitment to fueling scientific innovation and driving progress within the specialty chemicals sector. We look forward to leveraging these resources to expand our services, reach new markets, and continue providing unparalleled chemical solutions to industries worldwide.